Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Stem Cell ; 13(5): 535-48, 2013 Nov 07.
Article in English | MEDLINE | ID: mdl-24054998

ABSTRACT

In jawed vertebrates, development of an adaptive immune-system is essential for protection of the born organism against otherwise life-threatening pathogens. Myeloid cells of the innate immune system are formed early in development, whereas lymphopoiesis has been suggested to initiate much later, following emergence of definitive hematopoietic stem cells (HSCs). Herein, we demonstrate that the embryonic lymphoid commitment process initiates earlier than previously appreciated, prior to emergence of definitive HSCs, through establishment of a previously unrecognized entirely immune-restricted and lymphoid-primed progenitor. Notably, this immune-restricted progenitor appears to first emerge in the yolk sac and contributes physiologically to the establishment of lymphoid and some myeloid components of the immune-system, establishing the lymphomyeloid lineage restriction process as an early and physiologically important lineage-commitment step in mammalian hematopoiesis.


Subject(s)
Hematopoietic Stem Cells/cytology , Animals , Cell Differentiation/physiology , Cells, Cultured , Female , Gene Expression Regulation, Developmental/genetics , Gene Expression Regulation, Developmental/physiology , Hematopoietic Stem Cells/metabolism , Lymphocytes/cytology , Lymphocytes/metabolism , Male , Mice , Myeloid Cells/cytology , Myeloid Cells/metabolism , Polymerase Chain Reaction
2.
PLoS One ; 8(12): e82403, 2013.
Article in English | MEDLINE | ID: mdl-24386094

ABSTRACT

Purification of cardiomyocytes from the embryonic mouse heart, embryonic stem (ES) or induced pluripotent stem cells (iPS) is a challenging task and will require specific isolation procedures. Lately the significance of surface markers for the isolation of cardiac cell populations with fluorescence activated cell sorting (FACS) has been acknowledged, and the hunt for cardiac specific markers has intensified. As cardiomyocytes have traditionally been characterized by their expression of specific transcription factors and structural proteins, and not by specific surface markers, this constitutes a significant bottleneck. Lately, Flk-1, c-kit and the cellular prion protein have been reported to specify cardiac progenitors, however, no surface markers have so far been reported to specify a committed cardiomyocyte. Herein show for the first time, that embryonic cardiomyocytes can be isolated with 98% purity, based on their expression of vascular cell adhesion molecule-1 (VCAM-1). The FACS-isolated cells express phenotypic markers for embryonic committed cardiomyocytes but not cardiac progenitors. An important aspect of FACS is to provide viable cells with retention of functionality. We show that VCAM-1 positive cardiomyocytes can be isolated with 95% viability suitable for in vitro culture, functional assays or expression analysis. In patch-clamp experiments we provide evidence of functionally intact cardiomyocytes of both atrial and ventricular subtypes. This work establishes that cardiomyocytes can be isolated with a high degree of purity and viability through FACS, based on specific surface marker expression as has been done in the hematopoietic field for decades. Our FACS protocol represents a significant advance in which purified populations of cardiomyocytes may be isolated and utilized for downstream applications, such as purification of ES-cell derived cardiomyocytes.


Subject(s)
Myocytes, Cardiac/cytology , Vascular Cell Adhesion Molecule-1/metabolism , Animals , Biomarkers/metabolism , Cell Culture Techniques , Cell Proliferation , Cells, Cultured , Embryo, Mammalian/cytology , Flow Cytometry , Mice , Mice, Inbred C57BL , Myocardium/metabolism , Myocytes, Cardiac/metabolism
3.
PLoS One ; 6(11): e27500, 2011.
Article in English | MEDLINE | ID: mdl-22140444

ABSTRACT

Lack of expression of dystrophin leads to degeneration of muscle fibers and infiltration of connective and adipose tissue. Cell transplantation therapy has been proposed as a treatment for intractable muscle degenerative disorders. Several reports have demonstrated the ability of bone-marrow derived cells (BMDC) to contribute to non-haematopoietic tissues including epithelium, heart, liver, skeletal muscle and brain following transplantation by means of fusion and reprogramming. A key issue is the extent to which fusion and reprogramming can occur in vivo, particularly under conditions of myogenic deterioration.To investigate the therapeutic potential of bone marrow transplantation in monogenetic myopathy, green fluorescent protein-positive (GFP+) bone marrow cells were transplanted into non-irradiated c-kit receptor-deficient (W4¹) mdx mice. This model allows BMDC reconstitution in the absence of irradiation induced myeloablation. We provide the first report of BMDC fusion in a W4¹Dmd(mdx) deficient mouse model.In the absence of irradiation induced injury, few GFP+ cardiomyocytes and muscle fibres were detected 24 weeks post BMT. It was expected that the frequency of fusion in the hearts of W4¹Dmd(mdx) mice would be similar to frequencies observed in infarcted mice. Although, it is clear from this study that individual cardiomyocytes with monogenetic deficiencies can be rescued by fusion, it is as clear that in the absence of irradiation, the formation of stable and reprogrammed fusion hybrids occurs, with the current techniques, at very low levels in non-irradiated recipients.


Subject(s)
Bone Marrow Cells/cytology , Cellular Reprogramming , Muscle Development , Muscular Dystrophy, Animal/pathology , Proto-Oncogene Proteins c-kit/metabolism , Animals , Bone Marrow Cells/metabolism , Bone Marrow Transplantation , Cell Fusion , Disease Models, Animal , Green Fluorescent Proteins/metabolism , Hematopoiesis , Mice , Mice, Inbred C57BL , Mice, Inbred mdx , Muscle Fibers, Skeletal/metabolism , Muscle Fibers, Skeletal/pathology , Muscular Dystrophy, Animal/metabolism , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Reproducibility of Results , Whole-Body Irradiation
4.
Cardiovasc Res ; 86(3): 365-73, 2010 Jun 01.
Article in English | MEDLINE | ID: mdl-20071355

ABSTRACT

AIMS: Adult mammalian cardiomyocytes are traditionally viewed as being permanently withdrawn from the cell cycle. Whereas some groups have reported none, others have reported extensive mitosis in adult myocardium under steady-state conditions. Recently, a highly specific assay of 14C dating in humans has suggested a continuous generation of cardiomyocytes in the adult, albeit at a very low rate. Mice represent the most commonly used animal model for these studies, but their short lifespan makes them unsuitable for 14C studies. Herein, we investigate the cellular growth pattern for murine cardiomyocyte growth under steady-state conditions, addressed with new analytical and technical strategies, and we furthermore relate this to gene expression patterns. METHODS AND RESULTS: The observed levels of DNA synthesis in early life were associated with cardiomyocyte proliferation. Mitosis was prolonged into early life, longer than the most conservative previous estimates. DNA synthesis in neonatal life was attributable to bi-nucleation, therefore suggesting that cardiomyocytes withdraw from the cell cycle shortly after birth. No cell cycle activity was observed in adult cardiomyocytes and significant polyploidy was observed in cardiomyocyte nuclei. CONCLUSION: Gene analyses identified 32 genes whose expression was predicted to be particular to day 3-4 neonatal myocytes, compared with embryonic or adult cells. These cell cycle-associated genes are crucial to the understanding of the mechanisms of bi-nucleation and physiological cellular growth in the neonatal period.


Subject(s)
Cell Cycle , Cell Nucleus/physiology , Cell Proliferation , DNA Replication , Myocytes, Cardiac/physiology , Aging , Animals , Animals, Newborn , Bromodeoxyuridine/metabolism , Cell Cycle/genetics , Cell Nucleus/metabolism , Cell Separation/methods , Cells, Cultured , Flow Cytometry , Gene Expression Regulation, Developmental , Gestational Age , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Immunohistochemistry , Ki-67 Antigen/metabolism , Kinetics , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Transgenic , Mitosis , Myocytes, Cardiac/metabolism , Polyploidy , Reverse Transcriptase Polymerase Chain Reaction , Troponin T/metabolism
5.
Circ Res ; 97(10): 1036-45, 2005 Nov 11.
Article in English | MEDLINE | ID: mdl-16224065

ABSTRACT

Platelet-derived growth factor (PDGF)-D is a member of the PDGF/vascular endothelial growth factor family that activates PDGF receptor beta (PDGFR-beta). We show that PDGF-D is highly expressed in the myocardium throughout development and adulthood, as well as by arterial vascular smooth muscle cells (vSMCs). To obtain further knowledge regarding the in vivo response to PDGF-D, we generated transgenic mice overexpressing the active core domain of PDGF-D in the heart. Transgenic PDGF-D stimulates proliferation of cardiac interstitial fibroblasts and arterial vSMCs. This results in cardiac fibrosis followed by dilated cardiomyopathy and subsequent cardiac failure. Transgenic mice also display vascular remodeling, including dilation of vessels, increased density of SMC-coated vessels, and proliferation of vSMCs, leading to a thickening of tunica media. The thickening of arterial walls is a unique feature of PDGF-D, because this is not seen when PDGF-C is overexpressed in the heart. These results show that PDGF-D, via PDGFR-beta signaling, is a potent modulator of both vascular and connective tissue growth and may provide both paracrine and autocrine stimulation of PDGFR-beta. Our data raise the possibility that this growth factor may be involved in cardiac fibrosis and atherosclerosis.


Subject(s)
Lymphokines/physiology , Muscle, Smooth, Vascular/pathology , Myocardium/pathology , Platelet-Derived Growth Factor/physiology , Receptor, Platelet-Derived Growth Factor beta/physiology , Animals , Apolipoproteins E/physiology , Atherosclerosis/etiology , Cell Proliferation , Fibroblasts/physiology , Fibrosis , Humans , Lymphokines/analysis , Lymphokines/genetics , Mice , Mice, Transgenic , Myocardium/chemistry , Platelet-Derived Growth Factor/analysis , Platelet-Derived Growth Factor/genetics , RNA, Messenger/analysis , Receptor, Platelet-Derived Growth Factor beta/agonists , Receptor, Platelet-Derived Growth Factor beta/analysis , Signal Transduction
6.
J Clin Invest ; 115(1): 118-27, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15630451

ABSTRACT

The angiogenic mechanism and therapeutic potential of PDGF-CC, a recently discovered member of the VEGF/PDGF superfamily, remain incompletely characterized. Here we report that PDGF-CC mobilized endothelial progenitor cells in ischemic conditions; induced differentiation of bone marrow cells into ECs; and stimulated migration of ECs. Furthermore, PDGF-CC induced the differentiation of bone marrow cells into smooth muscle cells and stimulated their growth during vessel sprouting. Moreover, delivery of PDGF-CC enhanced postischemic revascularization of the heart and limb. Modulating the activity of PDGF-CC may provide novel opportunities for treating ischemic diseases.


Subject(s)
Endothelial Cells/cytology , Endothelial Cells/drug effects , Ischemia/drug therapy , Ischemia/pathology , Neovascularization, Physiologic/drug effects , Platelet-Derived Growth Factor/pharmacology , Stem Cells/drug effects , Animals , Cell Differentiation/drug effects , Cell Movement/drug effects , Cells, Cultured , Coronary Vessels/cytology , Coronary Vessels/drug effects , Hindlimb/blood supply , Hindlimb/drug effects , Humans , Ischemia/chemically induced , Ischemia/metabolism , Lymphokines , Mice , Microcirculation/drug effects , Myocardium/metabolism , Myocardium/pathology , Phosphotyrosine/metabolism , Receptors, Platelet-Derived Growth Factor/metabolism , Signal Transduction , Stem Cells/cytology
7.
Am J Pathol ; 163(2): 673-82, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12875986

ABSTRACT

The platelet-derived growth factors are implicated in development of fibrotic reactions and disease in several organs. We have overexpressed platelet-derived growth factor-C in the heart using the alpha-myosin heavy chain promoter and created a transgenic mouse that exhibits cardiac fibrosis followed by hypertrophy with sex-dependent phenotypes. The transgenic mice developed several pathological changes including cardiac fibroblast proliferation and deposition of collagen, hypertrophy, vascular defects, and the presence of Anitschkow cells in the adult myocardium. Male mice developed a hypertrophic phenotype, whereas female mice were more severely affected and developed dilated cardiomyopathy, leading to heart failure and sudden death. The vascular defects initially included dilation of microvessels and vascular leakage. Subsequently, a marked loss of microvessels, formation of large vascular sac-like structures, and an increased density of smooth muscle-coated vessels were observed in the myocardium. In part, the observed vascular changes may be because of an up-regulation of vascular endothelial growth factor in cardiac fibroblasts of the transgenic hearts. This unique animal model reveals that a potent mitogen for cardiac fibroblasts result in an expansion of the interstitium that induce a secondary sex-dependent hypertrophic response in the cardiomyocytes.


Subject(s)
Cardiomegaly/metabolism , Cardiomyopathy, Dilated/metabolism , Myocardium/metabolism , Myocardium/pathology , Platelet-Derived Growth Factor/metabolism , Animals , Biomarkers , Cardiomegaly/diagnostic imaging , Cardiomegaly/pathology , Cardiomyopathy, Dilated/diagnostic imaging , Cardiomyopathy, Dilated/pathology , Coronary Vessels/metabolism , Coronary Vessels/pathology , Echocardiography , Female , Fibroblasts/metabolism , Fibroblasts/pathology , Fibrosis , Gene Expression Regulation , Lymphokines , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Platelet-Derived Growth Factor/genetics , Promoter Regions, Genetic , Receptor, Platelet-Derived Growth Factor alpha/genetics , Receptor, Platelet-Derived Growth Factor alpha/metabolism , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...